| Product Name | GCNT3 Antibody, Biotin conjugated |
|---|---|
| Description | Rabbit polyclonal antibody against GCNT3 conjugated to Biotin |
| Synonyms | 2010013H22Rik antibody; 2210021I22Rik antibody; 2210401J11Rik antibody; 3-galactosyl-O-glycosyl-glycoprotein beta-1 antibody; 6-N-acetylglucosaminyltransferase 3 antibody; 6-N-acetylglucosaminyltransferase antibody; Beta 1 3 galactosyl O glycosyl glycoprotein beta 1 6 N acetylglucosaminyltransferase 3 antibody; Beta-1 antibody; Beta1 6 N acetylglucosaminyltransferase 3 antibody; beta1 6 N acetylglucosaminyltransferase antibody; C2/4GnT antibody; C24GNT antibody; C2GnT M antibody; C2GnT mucin type antibody; C2GnT-M antibody; C2GnT-mucin type antibody; C2GnT2 antibody; C2GNTM antibody; Core 2 beta 1 6 N acetylglucosaminyltransferase II antibody; Core 2/core 4 beta 1 6 N acetylglucosaminyltransferase antibody; Core 2/core 4 beta-1 antibody; dI/C2/C4GnT antibody; EC 2.4.1.102 antibody; EC 2.4.1.150 antibody; GCNT3 antibody; GCNT3_HUMAN antibody; Glucosaminyl (N acetyl) transferase 3 antibody; Glucosaminyl (N acetyl) transferase 3 mucin type antibody; glucosaminyl (N-acetyl) transferase 3, mucin type antibody; GnT M antibody; GNTM antibody; hC2GnT M antibody; hC2GnT-M antibody; Mucus-type core 2 beta-1,6-N-acetylglucosaminyltransferase antibody; OTTHUMP00000163601 antibody |
| Host | Rabbit |
| Clonality | Polyclonal |
| Conjugate | Biotin |
| Immunogen | Recombinant Human Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 protein (250-419AA) |
| Isotype | IgG |
| Target | GCNT3 |
| Reactivity | Human |
| Applications | ELISA |
| Form | Liquid |
| Diluent Buffer | Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 |
| Uniprot | O95395 |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
| Background | Glycosyltransferase that can synthesize all known mucin beta 6 N-acetylglucosaminides. Mediates core 2 and core 4 O-glycan branching, 2 important steps in mucin-type biosynthesis. Has also I-branching enzyme activity by converting linear into branched poly-N-acetyllactosaminoglycans, leading to introduce the blood group I antigen during embryonic development. |
| Supplier | Cusabio |
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.